$ USD
¥ 人民币
$ USD
€ 欧元
English
简体中文
English
繁体中文
Sign In / Sign up
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Menu
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Home
Medical drugs
Medical drugs
Medical drugs-Medical Halo Global Pharmaceutical News_Targeted Drugs_New Anti-Cancer Drugs_Overseas Medical Information_【Medical Halo Global Pharmaceutical】
Economic comparison of trientine and D-penicillamine in treatment
2026-02-01 22:25:32
Check Details
Adverse reaction management strategy of bosutinib/bosutinib in the treatment of chronic myelitis
2026-02-01 22:25:32
Check Details
What are the standard usage, dosage and precautions of Milizumab?
2026-02-01 22:25:32
Check Details
How effective is selumetinib in the treatment of glioma?
2026-02-01 22:25:32
Check Details
What are the main indications for nintedanib?
2026-02-01 22:25:32
Check Details
The efficacy of bimetinib combined with canafenib in the treatment of melanoma
2026-02-01 22:25:32
Check Details
The correct way to take Teclistamab-cqyv
2026-02-01 22:25:32
Check Details
How effective is Quizartinib in myeloid leukemia?
2026-02-01 22:25:32
Check Details
Isatuximab combined with pomalidomide and dexamethasone wins approval in China for multiple myeloma
2026-02-01 22:25:32
Check Details
What is the blood-brain barrier penetration mechanism of lapatinib in breast cancer?
2026-02-01 22:25:32
Check Details
What is the market price forecast for filgotinib in 2025?
2026-02-01 22:25:32
Check Details
What are the principles for dose adjustment of trientine in pediatric patients?
2026-02-01 22:25:32
Check Details
1
2
...
1632
1633
1634
1635
1636
1637
1638
...
2438
2439
Category
Oncology
Hepatobiliary
dermatology
Endocrinology
Hematology
Andrology
Gynecology
Nephrology
Urology
Department of Infectious Diseases
Gastroenterology
Respiratory department
Neurology
Cardiology and Brain Department
ophthalmology
Psychiatry
Immunology Department
orthopedics
Burn Department
相关知识
1
Tyrosine Kinase and JAK Inhibitors May Increase Keratinocyte Carcinoma Risk: New Research Reveals Drug Safety Findings
2
CLISGen Database: A New Tool for Cell Line Selection in Cancer Genetic Variation Research
3
RAS Targeted Therapy Resistance Breakthrough: mTORC1 is Key, Dalifarnib Combination Therapy Brings Hope
4
ARID1A Gene: A New Breakthrough in Tumor Immunotherapy, Turning "Cold Tumors" Hot
5
User Agreement
6
Herceptin Hylecta treats HER2-positive breast cancer and only needs to be injected subcutaneously and only used once every three weeks
7
What is the most important information I should know about WELIREG?
8
How to take and store WELIREG
9
How to take TRUSELTIQ correctly
10
How to deal with LONSURF side effects (1)
11
How to deal with LONSURF side effects (2)
12
Cabozantinib (Cabometyx)-new indication approved